Sponsor Pipeline

Suzhou Mednovo Yi Medical Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07391839 MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma. Hepatoma Recruiting
Disease Areas
Liver Cancer (1)
Get alerts when Suzhou Mednovo Yi Medical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free